Testicular cancer – interdisciplinary therapy

Close interdisciplinary collaboration between urology, oncology, radiation oncology but also pathology, radiology and vascular, visceral and thoracic surgery is crucial to achieve the best possible diagnosis, therapy and follow-up.


Testicular cancer is a rare disease, but the most common malignant tumor in young men. The excellent cure rates of this tumor disease are primarily based on adherence to the sometimes complex stage-adapted treatment guidelines. The certified Testicular Tumor Center of the University Hospital Zurich offers the platform for optimal care of testicular tumor patients with its interdisciplinary testicular tumor consultation and interdisciplinary tumor board, which is unique in Switzerland.

Possible therapies

  1. Surgical removal of part or all of the testis (with or without tissue removal for histological examination).
  2. Surgical removal of abdominal lymph nodes for metastatic testicular cancer.
  3. Drug therapy (chemotherapy) for high-risk and or metastatic testicular cancer.

Responsible doctors

Anja Lorch, Prof. Dr. med.

Senior Attending Physician, Vice Director of Department, Department of Medical Oncology and Hematology

Tel. +41 44 255 22 14
Specialties: Urological oncology (bladder, testicles, kidney, prostate)

Florian Schmid, Dr. med. Dr. sc. med.

Attending Physician, Department of Urology

Tel. +41 44 255 54 40
Specialties: Urological oncology (general and especially testicular and prostate cancer), Endourology (TUR prostate, TUR bladder, ureterorenoscopy)

For patients

You can either register for the testicular tumor consultation yourself or be referred by your primary care physician or your specialist.


For referrer

University Hospital Zurich
Department of Urology
Frauenklinikstr. 10, NORD1
8091 Zurich

Tel. +41 44 255 54 40
Assign online

Related diseases